清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013

医学 膀胱镜检查 膀胱癌 原位癌 泌尿科 化疗 尿路上皮癌 癌症 肿瘤科 内科学 泌尿系统
作者
Marko Babjuk,Maximilian Burger,Richard Zigeuner,Shahrokh F. Shariat,Bas W.G. van Rhijn,Éva Compérat,Richard Sylvester,Eero Kaasinen,Andreas Böhle,Joan Palou Redorta,Morgan Rouprêt
出处
期刊:European Urology [Elsevier]
卷期号:64 (4): 639-653 被引量:1117
标识
DOI:10.1016/j.eururo.2013.06.003
摘要

The first European Association of Urology (EAU) guidelines on bladder cancer were published in 2002 [1]. Since then, the guidelines have been continuously updated. To present the 2013 EAU guidelines on non–muscle-invasive bladder cancer (NMIBC). Literature published between 2010 and 2012 on the diagnosis and treatment of NMIBC was systematically reviewed. Previous guidelines were updated, and the levels of evidence and grades of recommendation were assigned. Tumours staged as Ta, T1, or carcinoma in situ (CIS) are grouped as NMIBC. Diagnosis depends on cystoscopy and histologic evaluation of the tissue obtained by transurethral resection (TUR) in papillary tumours or by multiple bladder biopsies in CIS. In papillary lesions, a complete TUR is essential for the patient's prognosis. Where the initial resection is incomplete, where there is no muscle in the specimen, or where a high-grade or T1 tumour is detected, a second TUR should be performed within 2–6 wk. The risks of both recurrence and progression may be estimated for individual patients using the EORTC scoring system and risk tables. The stratification of patients into low-, intermediate-, and high-risk groups is pivotal to recommending adjuvant treatment. For patients with a low-risk tumour, one immediate instillation of chemotherapy is recommended. Patients with an intermediate-risk tumour should receive one immediate instillation of chemotherapy followed by 1 yr of full-dose bacillus Calmette-Guérin (BCG) intravesical immunotherapy or by further instillations of chemotherapy for a maximum of 1 yr. In patients with high-risk tumours, full-dose intravesical BCG for 1–3 yr is indicated. In patients at highest risk of tumour progression, immediate radical cystectomy should be considered. Cystectomy is recommended in BCG-refractory tumours. The long version of the guidelines is available from the EAU Web site: http://www.uroweb.org/guidelines/. These abridged EAU guidelines present updated information on the diagnosis and treatment of NMIBC for incorporation into clinical practice. The EAU Panel on Non-muscle Invasive Bladder Cancer released an updated version of their guidelines. Current clinical studies support patient selection into different risk groups; low, intermediate and high risk. These risk groups indicate the likelihood of the development of a new (recurrent) cancer after initial treatment (endoscopic resection) or progression to more aggressive (muscle-invasive) bladder cancer and are most important for the decision to provide chemo- or immunotherapy (bladder installations). Surgical removal of the bladder (radical cystectomy) should only be considered in patients who have failed chemo- or immunotherapy, or who are in the highest risk group for progression.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
9秒前
511完成签到 ,获得积分10
28秒前
John完成签到 ,获得积分10
1分钟前
科研通AI2S应助科研通管家采纳,获得10
3分钟前
KKK完成签到,获得积分10
3分钟前
FashionBoy应助KKK采纳,获得10
3分钟前
4分钟前
KKK发布了新的文献求助10
4分钟前
Billy应助KKK采纳,获得10
4分钟前
灵巧白安完成签到 ,获得积分10
6分钟前
ZhiyunXu2012完成签到 ,获得积分10
7分钟前
纯纯纯纯完成签到,获得积分10
7分钟前
yichun完成签到,获得积分10
8分钟前
和谐小南完成签到,获得积分10
9分钟前
未来可期完成签到,获得积分10
9分钟前
11分钟前
jeff发布了新的文献求助20
11分钟前
RRRabbit完成签到,获得积分10
12分钟前
随梦而飞应助RRRabbit采纳,获得10
13分钟前
寻道图强应助siriusgg采纳,获得30
13分钟前
Antonio完成签到 ,获得积分10
14分钟前
FMHChan完成签到,获得积分10
15分钟前
siriusgg完成签到,获得积分20
15分钟前
Yvon完成签到,获得积分10
16分钟前
Akim应助Yvon采纳,获得10
16分钟前
大气摩托完成签到,获得积分20
18分钟前
大气摩托发布了新的文献求助10
18分钟前
dolphin完成签到 ,获得积分0
18分钟前
jqliu发布了新的文献求助10
19分钟前
奈思完成签到 ,获得积分10
19分钟前
spark810应助科研通管家采纳,获得10
19分钟前
spark810应助科研通管家采纳,获得10
19分钟前
lixuebin完成签到 ,获得积分10
19分钟前
jqliu完成签到,获得积分10
20分钟前
20分钟前
小蘑菇应助科研通管家采纳,获得10
21分钟前
Yvon发布了新的文献求助10
21分钟前
超帅柚子完成签到 ,获得积分10
21分钟前
肆肆完成签到,获得积分10
24分钟前
NexusExplorer应助爱坤坤采纳,获得10
26分钟前
高分求助中
Sustainability in Tides Chemistry 1500
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Threaded Harmony: A Sustainable Approach to Fashion 799
Livre et militantisme : La Cité éditeur 1958-1967 500
Retention of title in secured transactions law from a creditor's perspective: A comparative analysis of selected (non-)functional approaches 500
"Sixth plenary session of the Eighth Central Committee of the Communist Party of China" 400
Introduction to Modern Controls, with illustrations in MATLAB and Python 310
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3056622
求助须知:如何正确求助?哪些是违规求助? 2713084
关于积分的说明 7434592
捐赠科研通 2358176
什么是DOI,文献DOI怎么找? 1249304
科研通“疑难数据库(出版商)”最低求助积分说明 607027
版权声明 596227